A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Nature Medicine

• Publication date

  2021-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41591-021-01323-8PMID 33958794
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell Lineage and Pseudotime Inference for Single-cell Transcriptomics Analysis of Chemoresistance in GBM (P11-13.002)

  2023cited by this paper
• Durvalumab compared to maintenance chemotherapy in metastatic breast cancer: the randomized phase II SAFIR02-BREAST IMMUNO trial

  2021cited by this paper
• Tertiary lymphoid structures improve immunotherapy and survival in melanoma

  2020cited by this paper
• Fractalkine/CX3CL1 in Neoplastic Processes

  2020cited by this paper
• A conserved dendritic-cell regulatory program limits antitumour immunity

  2020cited by this paper
• Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study.

  2020cited by this paper
• B cells and tertiary lymphoid structures promote immunotherapy response

  2020cited by this paper
• B cells are associated with survival and immunotherapy response in sarcoma

  2020cited by this paper
• Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages

  2020cited by this paper
• Pembrolizumab for Early Triple-Negative Breast Cancer.

  2020cited by this paper
• Keytruda and PD-L1: a Real-World Example of Co-development of a Drug with a Predictive Biomarker

  2020cited by this paper
• A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling

  2020cited by this paper
• CellPhoneDB: inferring cell–cell communication from combined expression of multi-subunit ligand–receptor complexes

  2020cited by this paper
• The single-cell pathology landscape of breast cancer

  2020cited by this paper
• Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial.

  2019cited by this paper
• Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy.

  2019cited by this paper
• Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma.

  2019cited by this paper
• Immune-awakening revealed by peripheral T cell dynamics after one cycle of immunotherapy

  2019cited by this paper
• Clonal replacement of tumor-specific T cells following PD-1 blockade

  2019cited by this paper
• Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma

  2019cited by this paper
• Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.

  2019cited by this paper
• A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple negative breast cancer - clinical results and biomarker analysis of GeparNuevo study.

  2019cited by this paper
• A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer

  2019cited by this paper
• Generalizing RNA velocity to transient cell states through dynamical modeling

  2019cited by this paper
• The genomic landscape of nonsmall cell lung carcinoma in never smokers

  2019cited by this paper
• CD107a Degranulation Assay to Evaluate Immune Cell Antitumor Activity.

  2018cited by this paper
• Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression.

  2018cited by this paper
• UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction

  2018cited by this paper
• Integrating single-cell transcriptomic data across different conditions, technologies, and species

  2018cited by this paper
• Neoadjuvant PD‐1 Blockade in Resectable Lung Cancer

  2018cited by this paper
• Human dendritic cell subsets: an update

  2018cited by this paper
• Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.

  2018cited by this paper
• Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis

  2018cited by this paper
• Phenotype molding of stromal cells in the lung tumor microenvironment

  2018cited by this paper
• Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors

  2018cited by this paper
• Transcription factor Etv6 regulates functional differentiation of cross-presenting classical dendritic cells

  2018cited by this paper
• RNA velocity of single cells

  2018cited by this paper
• Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma

  2018cited by this paper
• LILRB4 signaling in leukemia cells mediates T cell suppression and tumor infiltration

  2018cited by this paper
• High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy.

  2018cited by this paper
• Single-cell reconstruction of the early maternal–fetal interface in humans

  2018cited by this paper
• Lineage tracking reveals dynamic relationships of T cells in colorectal cancer

  2018cited by this paper
• Dimensionality reduction for visualizing single-cell data using UMAP

  2018cited by this paper
• Intracellular Activation of Complement C3 Leads to PD-L1 Antibody Treatment Resistance by Modulating Tumor-Associated Macrophages

  2018cited by this paper
• Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment

  2018cited by this paper
• Comprehensive integration of single cell data

  2018cited by this paper
• Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma.

  2018cited by this paper
• Role of Antigen Spread and Distinctive Characteristics of Immunotherapy in Cancer Treatment

  2017cited by this paper
• Elements of cancer immunity and the cancer–immune set point

  2017cited by this paper
• Large-scale simultaneous measurement of epitopes and transcriptomes in single cells

  2017cited by this paper
• The transcription factor Runx3 guards cytotoxic CD8+ effector T cells against deviation towards follicular helper T cell lineage

  2017cited by this paper
• Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.

  2017cited by this paper
• Antigen receptor repertoire profiling from RNA-seq data

  2017cited by this paper
• Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics

  2017cited by this paper
• Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors

  2017cited by this paper
• Metallothioneins: Emerging Modulators in Immunity and Infection

  2017cited by this paper
• Development of a Prototype Immunohistochemistry Assay to Measure Programmed Death Ligand-1 Expression in Tumor Tissue.

  2016cited by this paper
• A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4+ T cell receptor repertoire clonality

  2015cited by this paper
• The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.

  2015cited by this paper
• MiXCR: software for comprehensive adaptive immunity profiling

  2015cited by this paper
• PD-1 blockade induces responses by inhibiting adaptive immune resistance

  2014cited by this paper
• an update on

  2014cited by this paper
• Ecological analysis of antigen-specific CTL repertoires defines the relationship between naïve and immune T-cell populations

  2013cited by this paper
• Comprehensive molecular portraits of human breast tumours

  2013cited by this paper
• Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98.

  2013cited by this paper
• Chemokine receptor CX3CR1 contributes to macrophage survival in tumor metastasis

  2013cited by this paper
• Comprehensive molecular portraits of human breast tumors

  2012cited by this paper
• pROC: an open-source package for R and S+ to analyze and compare ROC curves

  2011cited by this paper
• CTL mobilization to virus-infected tissue requires CD4+ T cell help

  2009cited by this paper
• Phenotypic and functional delineation of murine CX(3)CR1 monocyte-derived cells in ovarian cancer.

  2009cited by this paper
• Maturation pathways of dendritic cells determine TAP1 and TAP2 levels and cross‐presenting function

  2008cited by this paper
• TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance

  2005cited by this paper
• Dendritic Cell Maturation Requires STAT1 and Is under Feedback Regulation by Suppressors of Cytokine Signaling

  2004cited by this paper
• The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing

  1995cited by this paper

• Proteotranscriptomic Dissection of Breast Cancer T Cell States Identifies CD103+ Tfh-derived Cytotoxic Cells Linked to Immunotherapy Response

  2026cites this paper
• Obesity- and tumor-derived signals drive cancer-associated state transitions in breast mesenchymal stromal/stem cells reprogrammed by IL1RA or JAK inhibition

  2026influential citation
• A machine learning model integrating circulating Temra cell transcriptional profiles to predict immunotherapy efficacy.

  2026cites this paper
• Single-cell screens identify ADAM12 as a fibroblast checkpoint impeding anti-tumor immunity.

  2026cites this paper
• Immunotherapy-driven remodeling of the tumor immune microenvironment: Spatiotemporal heterogeneity and multidimensional dynamics.

  2026cites this paper
• Single-Cell Analysis of Chemotherapy-induced Remodeling Reveals CD276-driven Basal-like Chemoresistance in Pancreatic Cancer.

  2026cites this paper
• The interplay between cytokines and immune checkpoints in breast cancer therapy.

  2026cites this paper
• The role of programmed cell death 1 in autoimmune diseases: mechanisms and therapeutic implications

  2026cites this paper
• Bridging cancer cell-intrinsic driver genes and -extrinsic cell-cell communication with Driver2Comm.

  2026cites this paper
• Immune Predictors of Radiotherapy Outcomes in Cervical Cancer.

  2026cites this paper
• CA9+ cancer-associated fibroblasts cooperate with SPP1+ tumor-associated macrophages driving immune resistance in triple-negative breast cancer

  2026cites this paper
• T-cell receptor clonotypic diversity and specialization in digestive system cancers

  2026cites this paper
• Single-cell profiling of PBMCS reveals an immune signature of irAEs in anti-PD-1-treated acral melanoma patients

  2026cites this paper
• Reprogramming tumour-associated macrophages in breast cancer via si-FOXM1-loaded lipid nanoparticles enhances immune checkpoint inhibitor efficacy.

  2026cites this paper
• Multi-platform analysis of the tumor immune microenvironment associated with breast cancer subtypes

  2026cites this paper
• AugGCL: Multimodal graph learning for spatial transcriptomics analysis with enhanced gene and morphological data

  2026cites this paper
• Sensory neurons drive immune exclusion by stimulating a dense extracellular matrix in the breast cancer tumor microenvironment.

  2026cites this paper
• Molecular remodeling of cancer-associated fibroblasts in breast cancer patients receiving anti–PD-1 immunotherapy

  2026cites this paper
• TCR sequencing in cancer immunology and immunotherapy: what, when, where, why, and how

  2026cites this paper
• Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBC.

  2026cites this paper
• ABCA8-positive lipid-metabolic CAFs mediate immunotherapy resistance in TNBC

  2026cites this paper
• Evaluating deconvolution methods using real bulk RNA-expression data for robust prognostic insights across cancer types

  2026cites this paper
• The antitumor mechanism of polysaccharides through regulating the microbiota-metabolism-immune axis and their clinical application strategies.

  2026cites this paper
• Loss of Sox10 prevents tumor initiation and induces luminal-to-basal reprograming in a HER2+ mouse model

  2026cites this paper
• Pharmacological perturbation of splicing elicits SMG1 reduction: Implications for cancer therapy

  2026cites this paper
• Activated CD38+ mast cells promote gastric cancer progression by suppressing CD8+ T cell cytotoxic activity through adenosine metabolism.

  2026cites this paper
• JAK-STAT Pathway Heterogeneity Governs Immunotherapy Response in Breast Cancer

  2026cites this paper
• Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant immunochemotherapy in gastric cancer.

  2026cites this paper
• Smart responsive hydrogels combined with AI design for tumor therapy

  2026cites this paper
• Transcriptomic profiling of mouse mammary tumors enables prognostic and predictive biomarker discovery for human breast cancers

  2026influential citation
• Research Progress on Immunotherapeutics for Triple-Negative Breast Cancer from a Single-cell Perspective.

  2026cites this paper
• Decoding the tumor microenvironment remodeling orchestrated by CLEC3B+ inflammatory cancer-associated fibroblasts in lung adenocarcinoma immunotherapy: elucidation from pan-cancer spatially single-cell transcriptomics landscape

  2026cites this paper
• Host-derived interleukin-1α drives tumor immunosuppression by reprogramming tumor-associated myeloid cells

  2026cites this paper
• Radiation as an immune modulator: mechanisms and implications for combination with immunotherapy.

  2026cites this paper
• YAP/TEAD drives treatment-induced adaptive immunosuppression in EGFR-mutant lung cancer

  2026cites this paper
• Pan-cancer single cell transcriptomic clustering reveals heterogeneous CD8+ exhausted T cell populations with different immune checkpoint inhibitor responses

  2025cites this paper
• Multi-omics analysis of zinc finger protein 683 as a prognostic biomarker for immune infiltration in clear cell renal cell carcinoma

  2025cites this paper
• m6A-modified circZNF548 regulates exosomal miR-7108-3p to activate CD3+CD8+ T cells and suppress NSCLC growth by JMY

  2025cites this paper
• Modeling tumor relapse using proliferation tracing and ablation transgenic mouse

  2025cites this paper
• The untapped potential of radiation and immunotherapy for hormone receptor-positive breast cancer

  2025cites this paper
• Peripheral blood gene expression signatures of systemic immunity predict tumor microenvironment biology and therapeutic response in breast cancer

  2025cites this paper
• Inhibition of tumor cell macropinocytosis driver DHODH reverses immunosuppression and overcomes anti-PD1 resistance.

  2025cites this paper
• Application of single-cell and spatial omics in deciphering cellular hallmarks of cancer drug response and resistance

  2025cites this paper
• Single cell analysis of pan-cancer tumor microenvironment in immunotherapy.

  2025cites this paper
• Cancer-associated fibroblast-derived extracellular vesicles loaded with GLUT1 inhibitor synergize anti-PD-L1 to suppress tumor growth via degrading matrix stiffness and remodeling tumor microenvironment.

  2025cites this paper
• Dual ENPP1/ATM depletion blunts DNA damage repair boosting radioimmune efficacy to abrogate triple-negative breast cancer

  2025cites this paper
• Artesunate Nanoplatform Targets the Serine–MAPK Axis in Cancer‐Associated Fibroblasts to Reverse Photothermal Resistance in Triple‐Negative Breast Cancer

  2025cites this paper
• Knowledge-guided Contextual Gene Set Analysis Using Large Language Models

  2025cites this paper
• Jagged1 regulates extracellular matrix deposition and remodeling in triple-negative breast cancer

  2025influential citation
• Multi-cohort validation of a lipid metabolism and ferroptosis-associated index for prognosis and immunotherapy response prediction in hormone receptor-positive breast cancer

  2025cites this paper
• AAnet Resolves a Continuum of Spatially Localized Cell States to Unveil Intratumoral Heterogeneity

  2025cites this paper
• Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trial

  2025cites this paper
• Calcium Electrochemotherapy and Challenges in Combined Treatment with Dendritic Cell Vaccination

  2025cites this paper
• LaGrACE: estimating gene program dysregulation with latent regulatory network

  2025cites this paper
• Vγ9Vδ2 T Cells Express an Antitumor Profile Associated with Anti-PD-(L)1 Responses and Activation Defects Restored by Anti-BTN3A in Triple-Negative Breast Cancer.

  2025cites this paper
• PD-1 regulates tumor-infiltrating CD8+ T cells in both a cell-intrinsic and a cell-extrinsic fashion.

  2025cites this paper
• Incorporating hierarchical information into multiple instance learning for patient phenotype prediction with single-cell RNA-sequencing data

  2025cites this paper
• Multi-omics dissection of tumor microenvironment-mediated drug resistance: mechanisms and therapeutic reprogramming

  2025cites this paper
• Single‐Cell RNA Sequencing Reveals the Heterogeneity in Differentiation Trajectory and Tumor Microenvironment Leading to More Aggressive Phenotypes of Papillary Thyroid Cancer in Children and Young Adult Patients

  2025cites this paper
• CDK12/13 inactivation triggers STING-mediated antitumor immunity in preclinical models

  2025cites this paper
• Lipid nanoparticle-delivered IFNα2 activates Cxcl9 to increase T cell tumor recruitment to suppress lung metastasis

  2025cites this paper
• Dynamic Tumor Immune Microenvironment Remodeling Predicts Response of Checkpoint Inhibitor Therapy

  2025cites this paper
• Paracrine Orchestration of Tumor Microenvironment Remodeling Induced by GLO1 Potentiates Lymph Node Metastasis in Breast Cancer

  2025cites this paper
• Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype

  2025cites this paper
• Enhanced immunotherapy response in lung adenocarcinoma patients with COPD: insights into tumor cells and immune microenvironment characteristics

  2025cites this paper
• Immature monocytic cells within tumors differentiate into immunosuppressive cells in resistant tumors to immunotherapy

  2025cites this paper
• Deciphering the Immunomodulatory Function of GSN + Inflammatory Cancer‐Associated Fibroblasts in Renal Cell Carcinoma Immunotherapy: Insights From Pan‐Cancer Single‐Cell Landscape and Spatial Transcriptomics Analysis

  2025cites this paper
• The interplay between the immune response and neoadjuvant therapy in breast cancer

  2025cites this paper
• Tumour-derived microparticles obtained through microwave irradiation induce immunogenic cell death in lung adenocarcinoma

  2025cites this paper
• A coagulation-related long non-coding RNA signature to predict prognosis and immune features of breast cancer

  2025cites this paper
• Single-cell and multi-omics integration reveals cholesterol biosynthesis as a synergistic target with HER2 in aggressive breast cancer

  2025cites this paper
• Why combine and why neoadjuvant? Tumor immunological perspectives on chemoimmunotherapy in triple-negative breast cancer

  2025cites this paper
• Efficacy, safety and exploratory analysis of neoadjuvant tislelizumab (a PD-1 inhibitor) plus nab-paclitaxel followed by epirubicin/cyclophosphamide for triple-negative breast cancer: a phase 2 TREND trial

  2025cites this paper
• PDT-regulated immune gene prognostic model reveals tumor microenvironment in colorectal cancer liver metastases

  2025cites this paper
• Exploring the tumor microenvironment of breast cancer to develop a prognostic model and predict immunotherapy responses

  2025cites this paper
• Emerging Advances in the Molecular Landscape of Penile Cancer and Their Implications for Precision Medicine

  2025cites this paper
• Immunogenomic cancer evolution: A framework to understand cancer immunosuppression.

  2025cites this paper
• Uncovering gene and cellular signatures of immune checkpoint response via machine learning and single-cell RNA-seq

  2025cites this paper
• A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer.

  2025cites this paper
• Microbiota-reprogrammed phosphatidylcholine inactivates cytotoxic CD8 T cells through UFMylation via exosomal SerpinB9 in multiple myeloma

  2025cites this paper
• Benchmarking and optimizing organism wide single-cell RNA alignment methods

  2025cites this paper
• Reference-informed evaluation of batch correction for single-cell omics data with overcorrection awareness

  2025cites this paper
• Senescence-related cytokine levels are associated with HIV-1 serostatus and persistence.

  2025cites this paper
• Regulatory T Cell Infiltration-Driven Single-Cell Transcriptomic Analysis Identifies SAP18 as a Prognostic Marker for Esophageal Squamous Cell Carcinoma

  2025cites this paper
• A spatial transcriptomics study of MES-like and mono/macro cells in gliomas

  2025cites this paper
• New horizons at the interface of artificial intelligence and translational cancer research.

  2025cites this paper
• Immune Niche Formation in Engineered Mouse Models Reveals Mechanisms of Tumor Dormancy

  2025cites this paper
• Single-cell profiling in ovarian germ cell and sex cord-stromal tumours

  2025cites this paper
• Spatial analysis identifies DC niches as predictors of pembrolizumab therapy in head and neck squamous cell cancer

  2025cites this paper
• Tebentafusp elicits on-target cutaneous immune responses driven by cytotoxic T cells in uveal melanoma patients

  2025cites this paper
• Semaphorin7A and PD-L1 cooperatively drive immunosuppression during mammary involution and breast cancer

  2025cites this paper
• Single-Cell RNA Sequencing Reveals the Immune Landscape of Granulomatous Mastitis

  2025cites this paper
• Mechanoimmunological Control of Metastatic Site Selection

  2025cites this paper
• The impact of breast radiotherapy on the tumor genome and immune ecosystem.

  2025cites this paper
• Decipher: A computational pipeline to extract context-specific mechanistic insights from single-cell profiles

  2025cites this paper
• Interferon regulatory factor-1-expressing astrocytes are epigenetically controlled and exacerbate TBI-associated pathology in mice.

  2025cites this paper
• TCF7 enhances pulmonary hypertension by boosting stressed natural killer cells and their interaction with pulmonary arterial smooth muscle cells

  2025cites this paper
• Spatial transcriptomic analysis of immune checkpoint blockade response in triple negative breast cancers with tertiary lymphoid structures

  2025cites this paper
• Induction of tertiary lymphoid structures in tumor microenvironment to improve anti-tumoral immune checkpoint blockade efficacy.

  2025cites this paper
• Two chemotherapeutic agents expand stem-like CD62L+CD8+ T cells in antitumor immune responses

  2025cites this paper